SCHOLAR EDU (01769) announces the performance for 2025, with the company's owners bearing a loss of 77.718 million yuan, a year-on-year change from profit to loss.

16:56 31/03/2026

Thinking Education (01769) announced its performance in 2025, with a revenue of approximately 786 million yuan, a decrease of 7.8% year-on-year; gross profit of approximately 154 million yuan, a decrease of 53.8% year-on-year; the company's net loss attributable to owners is 77.718 million yuan, a year-on-year change from profit to loss; loss per share is 14.1 cents.

SCHOLAR EDU (01769) announced its performance for 2025, with revenue of approximately 786 million yuan, a decrease of 7.8% year-on-year; gross profit of about 154 million yuan, a decrease of 53.8% year-on-year; the company's net loss attributable to owners was 77.718 million yuan, turning from profit to loss year-on-year; loss per share was 14.1 cents. The announcement stated that the decrease in revenue was mainly due to a decrease in the total number of students enrolled and tutoring hours in 2025.

MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.

Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.

CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.

MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.

Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.

CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.